| Ident. | Authors (with country if any) | Title |
|---|
| 000453 |
Matthew E. Gegg [Royaume-Uni] ; J. Mark Cooper ; Kai-Yin Chau ; Manuel Rojo ; Anthony H. V. Schapira ; Jan-Willem Taanman | Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy |
| 000516 |
K. Ray Chaudhuri [Royaume-Uni] ; Cristina Prieto-Jurcynska [Espagne] ; Yogini Naidu [Royaume-Uni] ; Tanya Mitra [Royaume-Uni] ; Belen Frades-Payo [Espagne] ; Susanne Tluk [Royaume-Uni] ; Anne Ruessmann [Allemagne] ; Per Odin [Allemagne] ; Graeme Macphee [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; William Ondo [États-Unis] ; Kapil Sethi [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Juan Carlos Martinez Castrillo [Espagne] ; Pablo Martinez-Martin [Espagne] | The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire |
| 000569 |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 000732 |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 000C50 |
Anthony H. V. Schapira [Royaume-Uni] | The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease |
| 000F60 |
Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole |
| 001050 |
Anthony H. V. Schapira [Royaume-Uni] | Future directions in the treatment of Parkinson's disease |
| 001177 |
Anthony H. V. Schapira [Royaume-Uni, Espagne] ; Jose Obeso [Royaume-Uni, Espagne] | Timing of treatment initiation in Parkinson's disease: A need for reappraisal? |
| 001250 |
Anthony H. V. Schapira [Royaume-Uni] ; Erwan Bezard [France] ; Jonathan Brotchie [Canada] ; Frdric Calon [Canada] ; Graham L. Collingridge [Royaume-Uni] ; Borris Ferger [Allemagne] ; Bastian Hengerer [Allemagne] ; Etienne Hirsch [France] ; Peter Jenner [Royaume-Uni] ; Nicolas Le Novre [Royaume-Uni] ; Jos A. Obeso [Espagne] ; Michael A. Schwarzschild [États-Unis] ; Umberto Spampinato [France] ; Giora Davidai [États-Unis] | Novel pharmacological targets for the treatment of Parkinson's disease |
| 001763 |
Thomas T. Warner [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Genetic and environmental factors in the cause of Parkinson's disease |
| 002649 |
Dexter [Royaume-Uni] ; Peter Jenner [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia |
